Advertisement
Screener

Mersana Therapeutics, Inc. Form D

Mersana Therapeutics, Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2016-06-24: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2016-06-15; Total offering amount $33,099,988.
  • 2016-03-01: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2015-02-20; Total offering amount $35,450,006.
  • 2015-03-03: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2015-02-20; Total offering amount $35,450,006.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2016-06-24Rule 506(b)Equity2016-06-15$33,099,988$33,099,988$013
2016-03-01
D/A
Rule 506(b)Equity2015-02-20$35,450,006$10,128,576$25,321,43010
2015-03-03Rule 506(b)Equity2015-02-20$35,450,006$10,128,576$25,321,43010